To view or add a comment, sign in Apotex Launches Apo-Semaglutide Injection, Canada's Generic Equivalent of Ozempic Apotex has announced the commercial launch of Apo-Semaglutide Injection, a generic equivalent of Ozempic in Canada
Ready to get started with semaglutide
Retatrutide , a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, has shown weight loss exceeding 24% in clinical trials
Missing observations were multiply (x1000) imputed from retrieved participants of the same randomized treatment arm and missing value was replaced by the average across imputations
The starting dose of 0.25 mg is intentionally subtherapeutic
Which means when you book an appointment with us, thats ityou dont have to go to 3 other places beforehand